![](/img/cover-not-exists.png)
218TiP A phase Ib study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplation (MODURATE)
Taniguchi, H., Narita, Y., Kadowaki, S., Ura, T., Ando, M., Muro, K., Hamauchi, S., Tsushima, T., Yokota, T., Todaka, A., Machida, N., Fukutomi, A., Onozawa, Y., Yasui, H., Mori, K., Yamazaki, K.Volume:
27
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw581.050
Date:
December, 2016
File:
PDF, 64 KB
2016